FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice

Cholangiocarcinoma (CCA) is a heterogeneous group of neoplasms burdened by a dismal prognosis. Several studies have investigated the genomic profile of CCA and identified numerous druggable genetic alterations, including FGFR2 fusions/rearrangements. Approximately 5-7% of CCAs and 10-20% of intrahep...

Descripción completa

Detalles Bibliográficos
Autores principales: Angerilli, Valentina, Fornaro, Lorenzo, Pepe, Francesco, Rossi, Silvia Maria, Perrone, Giuseppe, Malapelle, Umberto, Fassan, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462997/
https://www.ncbi.nlm.nih.gov/pubmed/37017301
http://dx.doi.org/10.32074/1591-951X-859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462997/
https://www.ncbi.nlm.nih.gov/pubmed/37017301
http://dx.doi.org/10.32074/1591-951X-859

Ejemplares similares